Browsing Tag

Etranacogene Dezaparvovec

uniQure announces positive CHMP opinion for etranacogene dezaparvovec – gene therapy…

Eli Pacheco Dec 16, 2022 0

LEXINGTON, Mass. and AMSTERDAM, Dec. 16, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe…

Health

uniQure Announces Positive 52-Week Clinical Data from HOPE-B Pivotal Trial of …

Eli Pacheco Jun 23, 2021 0

~ Sustained increases in Factor IX (FIX) levels with mean FIX activity of 41.5 percent of normal in full study population one year following a single administration of etranacogene…